Rocket Pharmaceuticals (RCKT) Cash from Financing Activities (2014 - 2026)
Rocket Pharmaceuticals' Cash from Financing Activities came in at $150,000 for Q2 2026, down 30.2% from $215,000 a year earlier.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Rocket Pharmaceuticals reported Cash from Financing Activities of $82,000, down 100.0% year-over-year; for FY2025, it came in at $148,000, down 99.9% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -77.9% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $185.74 million in FY2024 (-10.9%), $208.4 million in FY2023 (+34.2%), $155.29 million in FY2022 (+312.1%) and $37.68 million in FY2021 (-86.7%).
- The five-year range for quarterly Cash from Financing Activities is -$67,000 (Q3 2025) to $189.49 million (Q3 2023).
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2024 (growth of 740.7%), and the weakest in Q3 2024 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - | 150,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 150,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Sep 30, 2025 | -67,000.00 |
| Jun 30, 2025 | 215,000.00 |
| Dec 31, 2024 | 182.85 Mn |
| Sep 30, 2024 | 176,000.00 |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 391,000.00 |
| Sep 30, 2023 | 189.49 Mn |
| Jun 30, 2023 | 182,000.00 |
| Mar 31, 2023 | 18.34 Mn |
| Dec 31, 2022 | 108.44 Mn |
| Sep 30, 2022 | 29.53 Mn |
| Jun 30, 2022 | 17.25 Mn |
| Mar 31, 2022 | 76,000.00 |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 26.64 Mn |
| Jun 30, 2021 | 1.12 Mn |
| Mar 31, 2021 | 8.79 Mn |
API Access
Rocket Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();